T. Rowe Price Associates, Inc. 13D and 13G filings for Utah Medical Products, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-08-10 2:56 pm Sale |
2022-07-31 | 13G | Utah Medical Products, Inc. UTMD |
T. Rowe Price Associates, Inc. | 22,155 0.600% |
-343,057 (-93.93%) |
Filing |
| 2022-06-10 10:11 am Purchase |
2022-05-31 | 13G | Utah Medical Products, Inc. UTMD |
T. Rowe Price Associates, Inc. | 365,212 10.000% |
22,537 (+6.58%) |
Filing |
| 2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | Utah Medical Products, Inc. UTMD |
T. Rowe Price Associates, Inc. | 342,675 9.300% |
62,547 (+22.33%) |
Filing |
| 2021-02-16 12:23 pm Sale |
2020-12-31 | 13G | Utah Medical Products, Inc. UTMD |
T. Rowe Price Associates, Inc. | 280,128 7.600% |
-38,555 (-12.10%) |
Filing |